🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

36+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 36 recruiting trials for “composite-lymphoma”

NARecruitingNCT05940272 ↗

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

👨‍⚕️ Kelly McConnell, PhD, Memorial Sloan Kettering Cancer Center📍 2 sites📅 Started Jul 2023View details ↗
NARecruitingNCT05662540 ↗

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

🏥 Ruijin Hospital📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05833893 ↗

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

👨‍⚕️ Yu Zhao, Graduate, Chief📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05477264 ↗

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

🏥 Won Seog Kim📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT06241729 ↗

Prospective Observational Study of Diffuse Large-cell B Lymphoma

👨‍⚕️ Delphine Pranger, MD, Grand Hôpital de Charleroi📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT06073938 ↗

Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

🏥 Hunan Province Tumor Hospital📍 1 site📅 Started Sep 2022View details ↗
RecruitingNCT05506410 ↗

A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma

👨‍⚕️ Zhang Mingzhi Zhang, The First Affiliated Hospital of Zhengzhou University📍 1 site📅 Started Aug 2022View details ↗
Phase 2RecruitingNCT04417166 ↗

Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma

👨‍⚕️ Stefano Luminari, MD, Ematologia, AUSL IRCCS Reggio Emilia📍 2 sites📅 Started Feb 2022View details ↗
Phase 1RecruitingNCT04807881 ↗

Phase Ib Clinical Study of Keynatinib

👨‍⚕️ Dawei Zhang, phD, Medolution Ltd.📍 4 sites📅 Started Sep 2020View details ↗
Phase 3RecruitingNCT04365036 ↗

A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)

🏥 Sun Yat-sen University📍 1 site📅 Started May 2020View details ↗
RecruitingNCT03494296 ↗

A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

👨‍⚕️ Shuye Wang, PhD, First Affiliated Hospital of Harbin Medical University📍 1 site📅 Started Mar 2018View details ↗
Phase 2RecruitingNCT02859402 ↗

Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

🏥 Keimyung University Dongsan Medical Center📍 2 sites📅 Started Dec 2016View details ↗
Phase 2RecruitingNCT02974647 ↗

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

👨‍⚕️ Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Nov 2016View details ↗
Phase 2RecruitingNCT02106988 ↗

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

👨‍⚕️ Bouthaina Dabaja, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2015View details ↗
Phase 1RecruitingNCT01555892 ↗

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

👨‍⚕️ Helen E Heslop, MD, Baylor College of Medicine📍 3 sites📅 Started Jan 2013View details ↗
Enrolling by InvitationNCT01382082 ↗

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

👨‍⚕️ Michelle C. Janelsins, PhD, University of Rochester📍 29 sites📅 Started Jul 2011View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →